INTRODUCTION: The increase in the prevalence of multidrug-resistant Acinetobacter
baumannii infections in hospital settings has rapidly emerged worldwide as a serious health …

Carbapenemases are β-lactamase enzymes that hydrolyze a variety of β-lactams including
carbapenem and belong to different Ambler classes (A, B, D). These enzymes can be …

The drug resistance rate of Acinetobacter baumannii increases year on year, and the drugs
available for the treatment of carbapenem-resistant A. baumannii (CRAB) infection are …

Antibiotic sensitivity spectrum of isolated strains differs according to hospital departments,
the hospitals themselves, and countries. Discrepancies also exist in terms of antibiotic use …

Antimicrobial resistance (AMR) is an increasing global concern, increasing costs, morbidity,
and mortality. National action plans (NAPs) to minimize AMR are one of several global and …

Aim Acinetobacter baumannii is a well‐known nosocomial pathogen that has been isolated
from different clinical sources. This pathogen also causes community‐acquired infections …

Abstract Carbapenem resistance in Enterobacteriaceae, Acinetobacter baumannii, and
Pseudomonas aeruginosa is increasing worldwide, which led the WHO to list these bacteria …

Acinetobacter baumannii (A. baumannii) represents a global threat owing to its ability to
resist most of the currently available antimicrobial agents. Moreover, emergence of …

Carbapenemases-producing K. pneumoniae are challenging antimicrobial therapy of
hospitalised patients, which is further complicated by colistin resistance. The aim of this …

INTRODUCTION: The behavior of methicillin-resistant Staphylococcus aureus (MRSA)
isolated from central venous catheter-related infection was evaluated to determine its biofilm …